⚕ GalenOps CRO console
← 717 (USA)

717-1109

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 717 (USA) (Dr. Reyes) · consented 2014-01-27
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild CONFUSIONAL STATE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-20 (study day 25.0); relationship: REMOTE

mild assessed 2026-08-18

Mild HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2014-02-15 (study day 20.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild INCREASED APPETITE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-29 (study day 3.0); relationship: REMOTE

mild assessed 2026-08-18

Mild INCREASED APPETITE — outcome: RECOVERED/RESOLVED; onset 2014-01-29 (study day 3.0); relationship: REMOTE

mild assessed 2026-08-18

Mild INSOMNIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-22 (study day 27.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild PRURITUS GENERALISED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-04 (study day 37.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-15 (study day 20.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild VENTRICULAR EXTRASYSTOLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04-18 (study day 82.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.